亞威股份(002559.SZ):目前主營業務不含光觸媒產品
格隆匯5月20日丨亞威股份(002559.SZ)在投資者互動平台表示,公司控股孫公司江蘇亞威艾歐斯激光科技有限公司的精密激光加工設備產品可用於顯示面板、半導體、新能源等業務領域,目前其重點圍繞顯示面板行業實現業務規模快速成長,在半導體行業尚未實現訂單突破。公司投資參股10.54%的威邁芯材(不納入公司合併報表範圍)具體情況詳見《關於對外投資暨關聯交易的公吿》(2021-015)。公司目前主營業務不含光觸媒產品。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.